European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

(2021) Richard J. Sylvester et al.   EUROPEAN UROLOGY

An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting

(2020) Jeremy Yuen-Chun Teoh et al.   EUROPEAN UROLOGY

Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

(2020) Marc-Oliver Grimm et al.   EUROPEAN UROLOGY

Fruit consumption and the risk of bladder cancer: A pooled analysis by the Bladder Cancer Epidemiology and Nutritional Determinants Study

(2020) Sylvia H. J. Jochems et al.   INTERNATIONAL JOURNAL OF CANCER

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

(2020) Stephen A Boorjian et al.   LANCET ONCOLOGY

Diagnostic accuracy, clinical utility and influence on decision making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer

(2019) David D'Andrea et al.   BJU INTERNATIONAL

Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors

(2019) Zhongbao Zhou et al.   WORLD JOURNAL OF UROLOGY

Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer – a follow-up five years after the start of treatment

(2019) Gun Danielsson et al.   Scandinavian Journal of Urology

Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis

(2019) Di Huang et al.   Frontiers in Oncology

Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer

(2019) Aaron Brant et al.   WORLD JOURNAL OF UROLOGY

An inverse association between the Mediterranean diet and bladder cancer risk: a pooled analysis of 13 cohort studies

(2019) Willem J. A. Witlox et al.   EUROPEAN JOURNAL OF NUTRITION

The Epidemiology of Bacillus Calmette-Guerin Infections after bladder instillation from 2002 through 2017: A Nationwide Retrospective Cohort Study

(2019) Emilie S. Larsen et al.   BJU INTERNATIONAL

Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy

(2019) Badrinath Konety et al.   EUROPEAN UROLOGY

The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial

(2019) Askin Eroglu et al.   International Journal of Clinical Oncology

Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?

(2019) Anouk E. Hentschel et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Eficacia y seguridad de distintas cepas de BCG en el tratamiento del tumor vesical en práctica clínica habitual

(2018) M. Unda-Urzaiz et al.   Actas Urologicas Espanolas

A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens

(2018) Andrea Mari et al.   BJU INTERNATIONAL

One year of experience using the Paris System for Reporting Urinary Cytology

(2018) Julie Meilleroux et al.   CANCER CYTOPATHOLOGY

Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients

(2018) Judith Bosschieter et al.   EUROPEAN UROLOGY

Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)

(2018) Valeria Panebianco et al.   EUROPEAN UROLOGY

Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review

(2018) Marcus G.K. Cumberbatch et al.   EUROPEAN UROLOGY

Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer on Tumor Recurrence

(2018) Edward M. Messing et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project

(2018) Rodolfo Hurle et al.   JOURNAL OF UROLOGY

Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought

(2018) J. Palou et al.   WORLD JOURNAL OF UROLOGY

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer

(2018) Francesco Soria et al.   WORLD JOURNAL OF UROLOGY

A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort

(2018) Nour-al-dain Marzouka et al.   Scientific Reports

Surgical checklist impact on recurrence-free survival of non-muscle invasive bladder cancer patients undergoing transurethral resection of bladder tumor

(2018) Rodrigo Suarez-Ibarrola et al.   BJU INTERNATIONAL

Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non–muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial

(2018) Wei Shen Tan et al.   EUROPEAN UROLOGY

An immediate, single intravesical instillation of mitomycin C is of benefit in patients with non–muscle-invasive bladder cancer irrespective of prognostic risk groups

(2018) Judith Bosschieter et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes

(2018) Marco Racioppi et al.   BMC CANCER

Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer

(2018) F. Johannes P. van Valenberg et al.   EUROPEAN UROLOGY

The value of immediate postoperative intravesical epirubicin instillation as an adjunct to standard adjuvant treatment in intermediate and high-risk non–muscle-invasive bladder cancer: A preliminary results of randomized controlled trial

(2018) Amr A. Elsawy et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review

(2017) Viktor Soukup et al.   EUROPEAN UROLOGY

Holmium YAG Photocoagulation: Safe and Economical Alternative to Transurethral Resection in Small Nonmuscle-Invasive Bladder Tumors

(2017) Jorge Planelles Gómez et al.   JOURNAL OF ENDOUROLOGY

Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case–Control Study

(2017) Christopher Martin et al.   JNCI-Journal of the National Cancer Institute

Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study

(2017) Laimonis Kavalieris et al.   JOURNAL OF UROLOGY

Efficacy of bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis

(2017) Brock E. Boehm et al.   JOURNAL OF UROLOGY

Comparative Effectiveness of Fluorescent Versus White Light Cystoscopy for Initial Diagnosis or Surveillance of Bladder Cancer on Clinical Outcomes: Systematic Review and Meta-Analysis

(2017) Roger Chou et al.   JOURNAL OF UROLOGY

How different cystoscopy methods influence patient sexual satisfaction, anxiety, and depression levels: a randomized prospective trial

(2017) Wojciech Krajewski et al.   QUALITY OF LIFE RESEARCH

Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case–Control Study

(2017) Christopher Martin et al.   JNCI-Journal of the National Cancer Institute

Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results

(2017) Tony W. Trinh et al.   Abdominal Radiology

Perioperative Intravesical Chemotherapy in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis

(2017) Michael R. Abern et al.   Journal of the National Comprehensive Cancer Network

Increasing age is not associated with toxicity leading to discontinuation of treatment in patients with urothelial non-muscle-invasive bladder cancer randomised to receive 3 years of maintenance bacille Calmette-Guérin: results from European Organisation

(2016) Jorg R. Oddens et al.   BJU INTERNATIONAL

The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging–Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging–Assisted TURBT in Primary Non–Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results

(2016) Seiji Naito et al.   EUROPEAN UROLOGY

Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non–Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study

(2016) Timo Marttila et al.   EUROPEAN UROLOGY

Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?

(2016) Richard J. Sylvester et al.   EUROPEAN UROLOGY

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

(2016) Samantha Cambier et al.   EUROPEAN UROLOGY

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer

(2016) Tom J.H. Arends et al.   EUROPEAN UROLOGY

Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies

(2016) Frits HM van Osch et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group

(2016) Ashish M. Kamat et al.   JOURNAL OF CLINICAL ONCOLOGY

Pioglitazone use and risk of bladder cancer: population based cohort study

(2016) Marco Tuccori et al.   BMJ-British Medical Journal

Pioglitazone use and risk of bladder cancer: population based cohort study

(2016) Marco Tuccori et al.   BMJ-British Medical Journal

Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinomain situof the urinary bladder

(2016) Eero Kaasinen et al.   Scandinavian Journal of Urology

Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin

(2015) Sümer Baltacı et al.   BJU INTERNATIONAL

Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy

(2015) Marco Moschini et al.   BJU INTERNATIONAL

The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin

(2015) Paolo Gontero et al.   BJU INTERNATIONAL

Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer

(2015) Daniel Ramirez et al.   BJU INTERNATIONAL

Long-term Outcome of Patients with Frequently Recurrent Non–muscle-invasive Bladder Carcinoma Treated with One Perioperative Plus Four Weekly Instillations of Mitomycin C Followed by Monthly Bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 Study

(2015) Riikka Järvinen et al.   EUROPEAN UROLOGY

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

(2015) Luis Martínez-Piñeiro et al.   EUROPEAN UROLOGY

Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial

(2015) Eduardo Solsona et al.   EUROPEAN UROLOGY

Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients

(2015) Paolo Gontero et al.   EUROPEAN UROLOGY

Efficacy and Safety of MCNA in Patients with Nonmuscle Invasive Bladder Cancer at High Risk for Recurrence and Progression after Failed Treatment with bacillus Calmette-Guérin

(2015) Alvaro Morales et al.   JOURNAL OF UROLOGY

Clinical Outcomes of cT1 Micropapillary Bladder Cancer

(2015) Daniel L. Willis et al.   JOURNAL OF UROLOGY

Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers: A matched-pair analysis

(2015) Naoya Niwa et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

BCG-refractory vs. BCG-relapsing non–muscle-invasive bladder cancer: A prospective cohort outcomes study

(2015) Harry W. Herr et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer

(2015) Faysal A. Yafi et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old

(2015) Eva Compérat et al.   VIRCHOWS ARCHIV

Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation

(2015) Rianne J. M. Lammers et al.   WORLD JOURNAL OF UROLOGY

Increased Lung and Bladder Cancer Incidence in Adults after In Utero and Early-Life Arsenic Exposure

(2014) C. Steinmaus et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Tumour stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer

(2014) Mohamed Bishr et al.   CUAJ-Canadian Urological Association Journal

Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection

(2014) Thomas Seisen et al.   CURRENT OPINION IN UROLOGY

The prognostic value of family history among patients with urinary bladder cancer

(2014) Lieke Egbers et al.   INTERNATIONAL JOURNAL OF CANCER

Combined Chemohyperthermia: 10-Year Single Center Experience in 160 Patients with Nonmuscle Invasive Bladder Cancer

(2014) Tom J.H. Arends et al.   JOURNAL OF UROLOGY

Reproducibility and Prognostic Value of WHO1973 and WHO2004 Grading Systems in TaT1 Urothelial Carcinoma of the Urinary Bladder

(2014) Ok Målfrid Mangrud et al.   PLoS One

Recent Advances in Imaging Cancer of the Kidney and Urinary Tract

(2014) Susan Hilton et al.   Surgical Oncology Clinics of North America

Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy

(2014) Thierry Roumeguère et al.   TRANSPLANT INTERNATIONAL

Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non–muscle-invasive bladder cancer with positive results on urine cytology

(2014) Yann Neuzillet et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Immediate Post–Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non–Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review

(2013) Nathan Perlis et al.   EUROPEAN UROLOGY

International Variations in Bladder Cancer Incidence and Mortality

(2013) Saurabh Chavan et al.   EUROPEAN UROLOGY

Effect of Smoking on Outcomes of Urothelial Carcinoma: A Systematic Review of the Literature

(2013) Joseph J. Crivelli et al.   EUROPEAN UROLOGY

Side Effects of Bacillus Calmette-Guérin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG

(2013) Maurizio Brausi et al.   EUROPEAN UROLOGY

Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines

(2013) Beate Pesch et al.   INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH

Outpatient urological procedures in antibiotic-naive patients with bladder cancer with asymptomatic bacteriuria

(2012) Harry W. Herr   BJU INTERNATIONAL

The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer

(2012) Mario Richterstetter et al.   BJU INTERNATIONAL

Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome

(2012) Polat Turker et al.   BJU INTERNATIONAL

Smoking Reduces the Efficacy of Intravesical Bacillus Calmette-Guérin Immunotherapy in Non–muscle-invasive Bladder Cancer

(2012) Michael Rink et al.   EUROPEAN UROLOGY

Follow-up After Surgical Treatment of Bladder Cancer: A Critical Analysis of the Literature

(2012) Viktor Soukup et al.   EUROPEAN UROLOGY

Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

(2012) Jorg Oddens et al.   EUROPEAN UROLOGY

A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage

(2011) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

Should Follow-up Cystoscopy in Bacillus Calmette-Guérin–Treated Patients Continue After Five Tumour-Free Years?

(2011) Sten Holmäng et al.   EUROPEAN UROLOGY

Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Guérin

(2011) Joan Palou et al.   EUROPEAN UROLOGY

Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis

(2011) Graham Mowatt et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guérin

(2009) Eleanor R. Ray et al.   BJU INTERNATIONAL

Long-term Efficacy of Maintenance Bacillus Calmette-Guérin versus Maintenance Mitomycin C Instillation Therapy in Frequently Recurrent TaT1 Tumours without Carcinoma In Situ: A Subgroup Analysis of the Prospective, Randomised FinnBladder I Study with a 20-Year Follow-up

(2009) Riikka Järvinen et al.   EUROPEAN UROLOGY

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

(2009) Per-Uno Malmström et al.   EUROPEAN UROLOGY

Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort

(2009) Hans-Martin Fritsche et al.   EUROPEAN UROLOGY

Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-α2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study

(2009) Miloš Duchek et al.   EUROPEAN UROLOGY

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

(2009) Richard J. Sylvester et al.   EUROPEAN UROLOGY

Photodynamic Diagnosis (5-Aminolevulinic Acid) of Transitional Cell Carcinoma After Bacillus Calmette-Guérin Immunotherapy and Mitomycin C Intravesical Therapy

(2009) Ronald O.P. Draga et al.   EUROPEAN UROLOGY

Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator Experience

(2009) Paramananthan Mariappan et al.   EUROPEAN UROLOGY

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

(2009) Jesus Fernandez-Gomez et al.   JOURNAL OF UROLOGY

Cystoscopy Revisited as the Gold Standard for Detecting Bladder Cancer Recurrence: Diagnostic Review Bias in the Randomized, Prospective CEFUB Trial

(2009) Madelon N.M. van der Aa et al.   JOURNAL OF UROLOGY

Diagnosis of urothelial carcinoma from urine

(2009) Bernard Têtu   MODERN PATHOLOGY

Recurrence at Three Months and High-grade Recurrence as Prognostic Factor of Progression in Multivariate Analysis of T1G2 Bladder Tumors

(2009) Juan Palou et al.   UROLOGY

The Schedule and Duration of Intravesical Chemotherapy in Patients with Non–Muscle-Invasive Bladder Cancer: A Systematic Review of the Published Results of Randomized Clinical Trials

(2008) Richard J. Sylvester et al.   EUROPEAN UROLOGY

Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy–Associated Adverse Events

(2008) J. Alfred Witjes et al.   EUROPEAN UROLOGY SUPPLEMENTS

Clinical outcomes of bacillus Calmette-Guérin instillation therapy for carcinoma in situ of urinary bladder

(2008) Atsushi Takenaka et al.   INTERNATIONAL JOURNAL OF UROLOGY

Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer

(2008) Seth P. Lerner et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Impact of Previous Bacille Calmette-Guérin Failure Pattern on Subsequent Response to Bacille Calmette-Guérin Plus Interferon Intravesical Therapy

(2008) Brian L. Gallagher et al.   UROLOGY

Going from evidence to recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal